Evidence map›Paper›PMID 33314744›Full record

Observational studyJournal of the International AIDS Society2020

24-Month HIV-free survival among HIV-exposed Infants in Lesotho: the PEAWIL cohort study.

Vincent J Tukei, Rhoderick Machekano, Michelle M Gill, Appolinaire Tiam, Majoalane Mokone, Anthony Isavwa, Malijane Nyabela, Tsietso Mots'oane, Seipati Nchephe, Mosilinyane Letsie and 2 more

Abstract readObservational Study
In one paragraph

Observational study in Journal of the International AIDS Society, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Vincent J TukeiElizabeth Glaser Pediatric AIDS Foundation, Maseru, Lesotho.ORCID 0000-0002-9525-2600
Rhoderick MachekanoElizabeth Glaser Pediatric AIDS Foundation, Washington, DC, USA.
Michelle M GillElizabeth Glaser Pediatric AIDS Foundation, Washington, DC, USA.
Appolinaire TiamElizabeth Glaser Pediatric AIDS Foundation, Washington, DC, USA.
Majoalane MokoneElizabeth Glaser Pediatric AIDS Foundation, Maseru, Lesotho.
Anthony IsavwaElizabeth Glaser Pediatric AIDS Foundation, Maseru, Lesotho.
Malijane NyabelaElizabeth Glaser Pediatric AIDS Foundation, Maseru, Lesotho.
Tsietso Mots'oaneMinistry of Health, Maseru, Lesotho.
Seipati NchepheMinistry of Health, Maseru, Lesotho.
Mosilinyane LetsieMinistry of Health, Maseru, Lesotho.
Seble G KassayeDepartment of Medicine, Georgetown University School of Medicine, Washington, DC, USA.
Laura GuayElizabeth Glaser Pediatric AIDS Foundation, Washington, DC, USA.

Funding

PEPFAR
6 · The paper itself

Abstract

introductionFollowing the implementation of the provision of lifelong antiretroviral therapy to all HIV-positive pregnant or breastfeeding women for prevention of mother-to-child transmission (PMTCT) of HIV by the Kingdom of Lesotho in 2013, we assessed the effectiveness of this approach by evaluating 24-month HIV-free survival among HIV-exposed infants (HEIs).

methodsWe conducted a prospective observational cohort study that enrolled HIV-positive and HIV-negative pregnant women, with follow-up of women and their infants for 24 months after delivery. Participant recruitment started in June 2014 and follow-up ended in September 2018. Trained nurses collected study information through patient interviews and chart abstraction at enrolment and every three to six months thereafter. Maternal HIV testing, infant mortality, HIV transmission and HIV-free survival rates were computed using Kaplan-Meier estimation. Cox regression hazard models were used to identify factors associated with infant HIV infection and death.

resultsBetween June 2014 and February 2016, we enrolled 653 HIV-positive and 941 HIV-negative pregnant women. Twenty-seven HIV-negative women acquired HIV during follow-up. Ultimately, 634 liveborn HEI (382 (52%) male, 303 (48%) female, 3 missing) and 839 who remained HIV-unexposed (HUIs) (409 (49.0%) male, 426 (51.0%) female, 4 missing) were followed; 550 HEIs and 701 HUIs completed the 24-month follow-up period. Of 607 (95.7%) HEIs who were tested for HIV at least once during follow-up, 17 were found to be HIV-positive. Two (9.5%) of 21 infants born to mothers who acquired HIV infection during follow-up were HIV-positive compared to 15 (2.4%) of 613 HEI born to women with known HIV infection. The risk of HIV transmission from HIV-positive mothers to their infants by 24 months of age was 2.9% (95% CI: 1.8 to 4.7). The estimated 24-month mortality rate among HEIs was 6.0% (95% CI: 4.4 to 8.2) compared to 3.8% (95% CI: 2.6 to 5.3) among HUIs (Log-rank p = 0.065). HIV-free survival at 24 months was 91.8% (95% CI: 89.2 to 93.7). Lower maternal age and birth weight were independently associated with increased HIV infection or death of infants.

conclusionsThe implementation of lifelong ART for PMTCT in the Lesotho public health system resulted in low HIV transmission, but survival of HEI remains lower than their HIV uninfected counterparts.

Indexed as

Infant MortalityAdolescentAdultAnti-HIV AgentsBreast FeedingFemaleHIV InfectionsHumansInfantInfant, NewbornInfectious Disease Transmission, VerticalMaleMiddle AgedPregnancyPregnancy Complications, InfectiousProspective StudiesAnti-HIV AgentsHIV-free survivalhuman immunodeficiency virusinfantLesothomortalitymother-to-child-transmissionprevention

Identifiers

PMID33314744
PMCPMC7733603

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.